APO Research
Talk to an analyst

APO RESEARCH · REPORT

Sintilimab Injection

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Sintilimab Injection Market Analysis and Forecast 2026-2032

22 December 2025199 pages

Choose your research edition.

Industry ResearchSintilimab Injection Industry Research Report 2026106 pages · $2,950 USDIndustry Growth & TrendsGlobal Sintilimab Injection Industry Growth and Trends Forecast to 203275 pages · $3,450 USDMarket StructureGlobal Sintilimab Injection Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032175 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Sintilimab Injection Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Sintilimab Injection Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Sintilimab Injection market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Sintilimab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Sintilimab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Sintilimab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Sintilimab Injection is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Sintilimab Injection include Innovant Biologics, Inc.. etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Sintilimab Injection, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Sintilimab Injection, also provides the sales of main regions and countries. Of the upcoming market potential for Sintilimab Injection, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Sintilimab Injection sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Sintilimab Injection market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Sintilimab Injection sales, projected growth trends, production technology, application and end-user industry.

Sintilimab Injection Segment by Company

Innovant Biologics, Inc.

Sintilimab Injection Segment by Type

100mg/10ml

Others

Sintilimab Injection Segment by Application

Hospitals

Clinics

Others

Sintilimab Injection Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Sintilimab Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Sintilimab Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Sintilimab Injection.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Sintilimab Injection in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Sintilimab Injection manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Sintilimab Injection sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Sintilimab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. 100mg/10ml Major Manufacturers Table 3. Others Major Manufacturers Table 4. Global Sintilimab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Hospitals Major Manufacturers Table 6. Clinics Major Manufacturers Table 7. Others Major Manufacturers Table 8. Sintilimab Injection Industry Trends Table 9. Sintilimab Injection Industry Drivers Table 10. Sintilimab Injection Industry Opportunities and Challenges Table 11. Sintilimab Injection Industry Restraints Table 12. Global Sintilimab Injection Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Sintilimab Injection Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Sintilimab Injection Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Sintilimab Injection Revenue Market Share by Region (2021-2026) Table 16. Global Sintilimab Injection Revenue Market Share by Region (2027-2032) Table 17. Global Sintilimab Injection Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 18. Global Sintilimab Injection Sales by Region (2021-2026) & (k units) Table 19. Global Sintilimab Injection Sales by Region (2027-2032) & (k units) Table 20. Global Sintilimab Injection Sales Market Share by Region (2021-2026) Table 21. Global Sintilimab Injection Sales Market Share by Region (2027-2032) Table 22. Global Sintilimab Injection Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Sintilimab Injection Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Sintilimab Injection Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Sintilimab Injection Sales Market Share by Manufacturers (2021-2026) Table 26. Global Sintilimab Injection Sales Price (US$/unit) of Manufacturers (2021-2026) Table 27. Global Sintilimab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Sintilimab Injection Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Sintilimab Injection Manufacturers, Product Type & Application Table 30. Global Sintilimab Injection Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Sintilimab Injection by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Sintilimab Injection Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Sintilimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Sintilimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Sintilimab Injection Revenue Market Share by Type (2021-2026) Table 37. Global Sintilimab Injection Revenue Market Share by Type (2027-2032) Table 38. Global Sintilimab Injection Sales by Type 2021 VS 2025 VS 2032 (k units) Table 39. Global Sintilimab Injection Sales by Type (2021-2026) & (k units) Table 40. Global Sintilimab Injection Sales by Type (2027-2032) & (k units) Table 41. Global Sintilimab Injection Sales Market Share by Type (2021-2026) Table 42. Global Sintilimab Injection Sales Market Share by Type (2027-2032) Table 43. Global Sintilimab Injection Price by Type (2021-2026) & (US$/unit) Table 44. Global Sintilimab Injection Price by Type (2027-2032) & (US$/unit) Table 45. Global Sintilimab Injection Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Sintilimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Sintilimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Sintilimab Injection Revenue Market Share by Application (2021-2026) Table 49. Global Sintilimab Injection Revenue Market Share by Application (2027-2032) Table 50. Global Sintilimab Injection Sales by Application 2021 VS 2025 VS 2032 (k units) Table 51. Global Sintilimab Injection Sales by Application (2021-2026) & (k units) Table 52. Global Sintilimab Injection Sales by Application (2027-2032) & (k units) Table 53. Global Sintilimab Injection Sales Market Share by Application (2021-2026) Table 54. Global Sintilimab Injection Sales Market Share by Application (2027-2032) Table 55. Global Sintilimab Injection Price by Application (2021-2026) & (US$/unit) Table 56. Global Sintilimab Injection Price by Application (2027-2032) & (US$/unit) Table 57. Innovant Biologics, Inc. Company Information Table 58. Innovant Biologics, Inc. Business Overview Table 59. Innovant Biologics, Inc. Sintilimab Injection Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 60. Innovant Biologics, Inc. Sintilimab Injection Product Portfolio Table 61. Innovant Biologics, Inc. Recent Development Table 62. North America Sintilimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 63. North America Sintilimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 64. North America Sintilimab Injection Sales by Type (2021-2026) & (k units) Table 65. North America Sintilimab Injection Sales by Type (2027-2032) & (k units) Table 66. North America Sintilimab Injection Sales Price by Type (2021-2026) & (US$/unit) Table 67. North America Sintilimab Injection Sales Price by Type (2027-2032) & (US$/unit) Table 68. North America Sintilimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 69. North America Sintilimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 70. North America Sintilimab Injection Sales by Application (2021-2026) & (k units) Table 71. North America Sintilimab Injection Sales by Application (2027-2032) & (k units) Table 72. North America Sintilimab Injection Sales Price by Application (2021-2026) & (US$/unit) Table 73. North America Sintilimab Injection Sales Price by Application (2027-2032) & (US$/unit) Table 74. North America Sintilimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 75. North America Sintilimab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 76. North America Sintilimab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 77. North America Sintilimab Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 78. North America Sintilimab Injection Sales by Country (2021-2026) & (k units) Table 79. North America Sintilimab Injection Sales by Country (2027-2032) & (k units) Table 80. North America Sintilimab Injection Sales Price by Country (2021-2026) & (US$/unit) Table 81. North America Sintilimab Injection Sales Price by Country (2027-2032) & (US$/unit) Table 82. United States Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 83. Canada Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 84. Mexico Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 85. Europe Sintilimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 86. Europe Sintilimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 87. Europe Sintilimab Injection Sales by Type (2021-2026) & (k units) Table 88. Europe Sintilimab Injection Sales by Type (2027-2032) & (k units) Table 89. Europe Sintilimab Injection Sales Price by Type (2021-2026) & (US$/unit) Table 90. Europe Sintilimab Injection Sales Price by Type (2027-2032) & (US$/unit) Table 91. Europe Sintilimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 92. Europe Sintilimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 93. Europe Sintilimab Injection Sales by Application (2021-2026) & (k units) Table 94. Europe Sintilimab Injection Sales by Application (2027-2032) & (k units) Table 95. Europe Sintilimab Injection Sales Price by Application (2021-2026) & (US$/unit) Table 96. Europe Sintilimab Injection Sales Price by Application (2027-2032) & (US$/unit) Table 97. Europe Sintilimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 98. Europe Sintilimab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 99. Europe Sintilimab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 100. Europe Sintilimab Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 101. Europe Sintilimab Injection Sales by Country (2021-2026) & (k units) Table 102. Europe Sintilimab Injection Sales by Country (2027-2032) & (k units) Table 103. Europe Sintilimab Injection Sales Price by Country (2021-2026) & (US$/unit) Table 104. Europe Sintilimab Injection Sales Price by Country (2027-2032) & (US$/unit) Table 105. Germany Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 106. France Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 107. U.K. Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 108. Italy Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 109. Russia Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 110. Spain Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 111. Netherlands Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 112. Switzerland Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 113. Sweden Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 114. Poland Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 115. China Sintilimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 116. China Sintilimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 117. China Sintilimab Injection Sales by Type (2021-2026) & (k units) Table 118. China Sintilimab Injection Sales by Type (2027-2032) & (k units) Table 119. China Sintilimab Injection Sales Price by Type (2021-2026) & (US$/unit) Table 120. China Sintilimab Injection Sales Price by Type (2027-2032) & (US$/unit) Table 121. China Sintilimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 122. China Sintilimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 123. China Sintilimab Injection Sales by Application (2021-2026) & (k units) Table 124. China Sintilimab Injection Sales by Application (2027-2032) & (k units) Table 125. China Sintilimab Injection Sales Price by Application (2021-2026) & (US$/unit) Table 126. China Sintilimab Injection Sales Price by Application (2027-2032) & (US$/unit) Table 127. Asia Sintilimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 128. Asia Sintilimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 129. Asia Sintilimab Injection Sales by Type (2021-2026) & (k units) Table 130. Asia Sintilimab Injection Sales by Type (2027-2032) & (k units) Table 131. Asia Sintilimab Injection Sales Price by Type (2021-2026) & (US$/unit) Table 132. Asia Sintilimab Injection Sales Price by Type (2027-2032) & (US$/unit) Table 133. Asia Sintilimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 134. Asia Sintilimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 135. Asia Sintilimab Injection Sales by Application (2021-2026) & (k units) Table 136. Asia Sintilimab Injection Sales by Application (2027-2032) & (k units) Table 137. Asia Sintilimab Injection Sales Price by Application (2021-2026) & (US$/unit) Table 138. Asia Sintilimab Injection Sales Price by Application (2027-2032) & (US$/unit) Table 139. Asia Sintilimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 140. Asia Sintilimab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 141. Asia Sintilimab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 142. Asia Sintilimab Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 143. Asia Sintilimab Injection Sales by Country (2021-2026) & (k units) Table 144. Asia Sintilimab Injection Sales by Country (2027-2032) & (k units) Table 145. Asia Sintilimab Injection Sales Price by Country (2021-2026) & (US$/unit) Table 146. Asia Sintilimab Injection Sales Price by Country (2027-2032) & (US$/unit) Table 147. Japan Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 148. South Korea Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 149. India Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 150. Australia Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 151. Taiwan Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 152. Southeast Asia Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 153. SAMEA Sintilimab Injection Revenue by Type (2021-2026) & (US$ Million) Table 154. SAMEA Sintilimab Injection Revenue by Type (2027-2032) & (US$ Million) Table 155. SAMEA Sintilimab Injection Sales by Type (2021-2026) & (k units) Table 156. SAMEA Sintilimab Injection Sales by Type (2027-2032) & (k units) Table 157. SAMEA Sintilimab Injection Sales Price by Type (2021-2026) & (US$/unit) Table 158. SAMEA Sintilimab Injection Sales Price by Type (2027-2032) & (US$/unit) Table 159. SAMEA Sintilimab Injection Revenue by Application (2021-2026) & (US$ Million) Table 160. SAMEA Sintilimab Injection Revenue by Application (2027-2032) & (US$ Million) Table 161. SAMEA Sintilimab Injection Sales by Application (2021-2026) & (k units) Table 162. SAMEA Sintilimab Injection Sales by Application (2027-2032) & (k units) Table 163. SAMEA Sintilimab Injection Sales Price by Application (2021-2026) & (US$/unit) Table 164. SAMEA Sintilimab Injection Sales Price by Application (2027-2032) & (US$/unit) Table 165. SAMEA Sintilimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 166. SAMEA Sintilimab Injection Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 167. SAMEA Sintilimab Injection Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 168. SAMEA Sintilimab Injection Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 169. SAMEA Sintilimab Injection Sales by Country (2021-2026) & (k units) Table 170. SAMEA Sintilimab Injection Sales by Country (2027-2032) & (k units) Table 171. SAMEA Sintilimab Injection Sales Price by Country (2021-2026) & (US$/unit) Table 172. SAMEA Sintilimab Injection Sales Price by Country (2027-2032) & (US$/unit) Table 173. Brazil Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 174. Argentina Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 175. Chile Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 176. Colombia Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 177. Peru Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 178. Saudi Arabia Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 179. Israel Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 180. UAE Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 181. Turkey Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 182. Iran Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 183. Egypt Sintilimab Injection Revenue (2021-2032) & (US$ Million) Table 184. Key Raw Materials Table 185. Raw Materials Key Suppliers Table 186. Sintilimab Injection Distributors List Table 187. Sintilimab Injection Customers List Table 188. Research Programs/Design for This Report Table 189. Authors List of This Report Table 190. Secondary Sources Table 191. Primary Sources List of Figures Figure 1. Sintilimab Injection Image Figure 2. Global Sintilimab Injection Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Sintilimab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 4. 100mg/10ml Image Figure 5. Others Image Figure 6. Global Sintilimab Injection Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Sintilimab Injection Market Size Share 2021 VS 2025 VS 2032 Figure 8. Hospitals Image Figure 9. Clinics Image Figure 10. Others Image Figure 11. Global Sintilimab Injection Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Sintilimab Injection Revenue (2021-2032) & (US$ Million) Figure 13. Global Sintilimab Injection Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Sintilimab Injection Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Sintilimab Injection Revenue Market Share by Region (2021-2032) Figure 16. Global Sintilimab Injection Sales (2021-2032) & (k units) Figure 17. Global Sintilimab Injection Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 18. Global Sintilimab Injection Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Sintilimab Injection Sales YoY (2021-2032) & (k units) Figure 20. Europe Sintilimab Injection Sales YoY (2021-2032) & (k units) Figure 21. China Sintilimab Injection Sales YoY (2021-2032) & (k units) Figure 22. Asia (Excluding China) Sintilimab Injection Sales YoY (2021-2032) & (k units) Figure 23. South America, Middle East and Africa Sintilimab Injection Sales YoY (2021-2032) & (k units) Figure 24. Global Sintilimab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Sintilimab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Sintilimab Injection Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Sintilimab Injection Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Sintilimab Injection Revenue Market Share by Type (2021-2032) Figure 30. Global Sintilimab Injection Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 31. Global Sintilimab Injection Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Sintilimab Injection Sales Market Share by Type (2021-2032) Figure 33. Global Sintilimab Injection Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Sintilimab Injection Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Sintilimab Injection Revenue Market Share by Application (2021-2032) Figure 36. Global Sintilimab Injection Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 37. Global Sintilimab Injection Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Sintilimab Injection Sales Market Share by Application (2021-2032) Figure 39. North America Sintilimab Injection Revenue Share by Type (2021-2032) Figure 40. North America Sintilimab Injection Sales Share by Type (2021-2032) Figure 41. North America Sintilimab Injection Revenue Share by Application (2021-2032) Figure 42. North America Sintilimab Injection Sales Share by Application (2021-2032) Figure 43. North America Sintilimab Injection Revenue Share by Country (2021-2032) Figure 44. North America Sintilimab Injection Sales Share by Country (2021-2032) Figure 45. Europe Sintilimab Injection Revenue Share by Type (2021-2032) Figure 46. Europe Sintilimab Injection Sales Share by Type (2021-2032) Figure 47. Europe Sintilimab Injection Revenue Share by Application (2021-2032) Figure 48. Europe Sintilimab Injection Sales Share by Application (2021-2032) Figure 49. Europe Sintilimab Injection Revenue Share by Country (2021-2032) Figure 50. Europe Sintilimab Injection Sales Share by Country (2021-2032) Figure 51. China Sintilimab Injection Revenue Share by Type (2021-2032) Figure 52. China Sintilimab Injection Sales Share by Type (2021-2032) Figure 53. China Sintilimab Injection Revenue Share by Application (2021-2032) Figure 54. China Sintilimab Injection Sales Share by Application (2021-2032) Figure 55. Asia Sintilimab Injection Revenue Share by Type (2021-2032) Figure 56. Asia Sintilimab Injection Sales Share by Type (2021-2032) Figure 57. Asia Sintilimab Injection Revenue Share by Application (2021-2032) Figure 58. Asia Sintilimab Injection Sales Share by Application (2021-2032) Figure 59. Asia Sintilimab Injection Revenue Share by Country (2021-2032) Figure 60. Asia Sintilimab Injection Sales Share by Country (2021-2032) Figure 61. SAMEA Sintilimab Injection Revenue Share by Type (2021-2032) Figure 62. SAMEA Sintilimab Injection Sales Share by Type (2021-2032) Figure 63. SAMEA Sintilimab Injection Revenue Share by Application (2021-2032) Figure 64. SAMEA Sintilimab Injection Sales Share by Application (2021-2032) Figure 65. SAMEA Sintilimab Injection Revenue Share by Country (2021-2032) Figure 66. SAMEA Sintilimab Injection Sales Share by Country (2021-2032) Figure 67. Sintilimab Injection Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Sintilimab Injection Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg/10ml
  • Others
Applications
  • Hospitals
  • Clinics
  • Others
Companies covered
  • Innovant Biologics, Inc.

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Sintilimab Injection Market by Type
  3. 1.2.1 Global Sintilimab Injection Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 100mg/10ml
  5. 1.2.3 Others
  6. 1.3 Sintilimab Injection Market by Application
  7. 1.3.1 Global Sintilimab Injection Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Hospitals
  9. 1.3.3 Clinics
  10. 1.3.4 Others
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Sintilimab Injection Market Dynamics
  1. 2.1 Sintilimab Injection Industry Trends
  2. 2.2 Sintilimab Injection Industry Drivers
  3. 2.3 Sintilimab Injection Industry Opportunities and Challenges
  4. 2.4 Sintilimab Injection Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Sintilimab Injection Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Sintilimab Injection Revenue by Region
  3. 3.2.1 Global Sintilimab Injection Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Sintilimab Injection Revenue by Region (2021-2026)
  5. 3.2.3 Global Sintilimab Injection Revenue by Region (2027-2032)
  6. 3.2.4 Global Sintilimab Injection Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Sintilimab Injection Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Sintilimab Injection Sales by Region
  9. 3.4.1 Global Sintilimab Injection Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Sintilimab Injection Sales by Region (2021-2026)
  11. 3.4.3 Global Sintilimab Injection Sales by Region (2027-2032)
  12. 3.4.4 Global Sintilimab Injection Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Sintilimab Injection Revenue by Manufacturers
  2. 4.1.1 Global Sintilimab Injection Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Sintilimab Injection Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Sintilimab Injection Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Sintilimab Injection Sales by Manufacturers
  6. 4.2.1 Global Sintilimab Injection Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Sintilimab Injection Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Sintilimab Injection Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Sintilimab Injection Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Sintilimab Injection Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Sintilimab Injection Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Sintilimab Injection Manufacturers, Product Type & Application
  13. 4.7 Global Sintilimab Injection Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Sintilimab Injection Market CR5 and HHI
  16. 4.8.2 2025 Sintilimab Injection Tier 1, Tier 2, and Tier 3
5 Sintilimab Injection Market by Type
  1. 5.1 Global Sintilimab Injection Revenue by Type
  2. 5.1.1 Global Sintilimab Injection Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Sintilimab Injection Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Sintilimab Injection Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Sintilimab Injection Sales by Type
  6. 5.2.1 Global Sintilimab Injection Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Sintilimab Injection Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Sintilimab Injection Sales Market Share by Type (2021-2032)
  9. 5.3 Global Sintilimab Injection Price by Type
6 Sintilimab Injection Market by Application
  1. 6.1 Global Sintilimab Injection Revenue by Application
  2. 6.1.1 Global Sintilimab Injection Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Sintilimab Injection Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Sintilimab Injection Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Sintilimab Injection Sales by Application
  6. 6.2.1 Global Sintilimab Injection Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Sintilimab Injection Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Sintilimab Injection Sales Market Share by Application (2021-2032)
  9. 6.3 Global Sintilimab Injection Price by Application
7 Company Profiles
  1. 7.1 Innovant Biologics, Inc.
  2. 7.1.1 Innovant Biologics, Inc. Company Information
  3. 7.1.2 Innovant Biologics, Inc. Business Overview
  4. 7.1.3 Innovant Biologics, Inc. Sintilimab Injection Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Innovant Biologics, Inc. Sintilimab Injection Product Portfolio
  6. 7.1.5 Innovant Biologics, Inc. Recent Developments
8 North America
  1. 8.1 North America Sintilimab Injection Market Size by Type
  2. 8.1.1 North America Sintilimab Injection Revenue by Type (2021-2032)
  3. 8.1.2 North America Sintilimab Injection Sales by Type (2021-2032)
  4. 8.1.3 North America Sintilimab Injection Price by Type (2021-2032)
  5. 8.2 North America Sintilimab Injection Market Size by Application
  6. 8.2.1 North America Sintilimab Injection Revenue by Application (2021-2032)
  7. 8.2.2 North America Sintilimab Injection Sales by Application (2021-2032)
  8. 8.2.3 North America Sintilimab Injection Price by Application (2021-2032)
  9. 8.3 North America Sintilimab Injection Market Size by Country
  10. 8.3.1 North America Sintilimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Sintilimab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Sintilimab Injection Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Sintilimab Injection Market Size by Type
  2. 9.1.1 Europe Sintilimab Injection Revenue by Type (2021-2032)
  3. 9.1.2 Europe Sintilimab Injection Sales by Type (2021-2032)
  4. 9.1.3 Europe Sintilimab Injection Price by Type (2021-2032)
  5. 9.2 Europe Sintilimab Injection Market Size by Application
  6. 9.2.1 Europe Sintilimab Injection Revenue by Application (2021-2032)
  7. 9.2.2 Europe Sintilimab Injection Sales by Application (2021-2032)
  8. 9.2.3 Europe Sintilimab Injection Price by Application (2021-2032)
  9. 9.3 Europe Sintilimab Injection Market Size by Country
  10. 9.3.1 Europe Sintilimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Sintilimab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Sintilimab Injection Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Sintilimab Injection Market Size by Type
  2. 10.1.1 China Sintilimab Injection Revenue by Type (2021-2032)
  3. 10.1.2 China Sintilimab Injection Sales by Type (2021-2032)
  4. 10.1.3 China Sintilimab Injection Price by Type (2021-2032)
  5. 10.2 China Sintilimab Injection Market Size by Application
  6. 10.2.1 China Sintilimab Injection Revenue by Application (2021-2032)
  7. 10.2.2 China Sintilimab Injection Sales by Application (2021-2032)
  8. 10.2.3 China Sintilimab Injection Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Sintilimab Injection Market Size by Type
  2. 11.1.1 Asia Sintilimab Injection Revenue by Type (2021-2032)
  3. 11.1.2 Asia Sintilimab Injection Sales by Type (2021-2032)
  4. 11.1.3 Asia Sintilimab Injection Price by Type (2021-2032)
  5. 11.2 Asia Sintilimab Injection Market Size by Application
  6. 11.2.1 Asia Sintilimab Injection Revenue by Application (2021-2032)
  7. 11.2.2 Asia Sintilimab Injection Sales by Application (2021-2032)
  8. 11.2.3 Asia Sintilimab Injection Price by Application (2021-2032)
  9. 11.3 Asia Sintilimab Injection Market Size by Country
  10. 11.3.1 Asia Sintilimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Sintilimab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Sintilimab Injection Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Sintilimab Injection Market Size by Type
  2. 12.1.1 SAMEA Sintilimab Injection Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Sintilimab Injection Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Sintilimab Injection Price by Type (2021-2032)
  5. 12.2 SAMEA Sintilimab Injection Market Size by Application
  6. 12.2.1 SAMEA Sintilimab Injection Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Sintilimab Injection Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Sintilimab Injection Price by Application (2021-2032)
  9. 12.3 SAMEA Sintilimab Injection Market Size by Country
  10. 12.3.1 SAMEA Sintilimab Injection Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Sintilimab Injection Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Sintilimab Injection Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Sintilimab Injection Value Chain Analysis
  2. 13.1.1 Sintilimab Injection Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Sintilimab Injection Production Mode & Process
  6. 13.2 Sintilimab Injection Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Sintilimab Injection Distributors
  9. 13.2.3 Sintilimab Injection Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst